CompoAtlas

Vaporizing ointment

Natural health product licensed in Canada

Licence holder
Pharmascience Inc. / Pendopharms, Division of Pharmascience Inc.
NPN or DIN-HM
00817562
Status
Inactive licence
Licence date
5 October 2009
Revision date
Not provided
Form
Onguent
Route of administration
Topique
Application type
DIN de transition

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
5-méthyl-2-isoprpoyl-1-phénol0.7 mg
(1R, 2S, 5R)-5-méthyl-2-(1-méthyléthyl)cyclohexanol

Source : Botanique

26 mg
Huile de feuille de cèdre

Source : Botanique

4 mg

Non-medicinal ingredients

Cire d'abeille, Gelée de pétrole blanche

PopulationAgeQuantity per servingFrequency
AdultesNot specified2 Cuillère à théNot specified
Enfantsminimum: 2 yearsNot specifiedminimum: 3 days ; maximum: 4 days
Enfantsmaximum: 2 yearsNot specifiedNot specified
Enfantsminimum: 2 years2 Cuillère à théNot specified
AdultesNot specifiedNot specifiedminimum: 3 days ; maximum: 4 days

Uses authorised in Canada

Décongestionnant nasal et antitussif / soulagement temporaire des douleurs musculaires.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 00817562

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line